发明名称 |
USE OF GLA OR DGLA FOR PREPARING A MEDICAMENT TO REDUCE PRODUCTION OF UNDESIRABLE METABOLITES FROM ARACHIDONIC ACID |
摘要 |
A method of preparation of a medicament for reducing the risk of production of undesirable metabolites from free bodily AA on administration of AA to currect deficiency thereof, wherein GLA and/or DGLA as such or in the form of a salt dissociated at physiological pH is prepared as said medicament alone or incorporated in a pharmaceutically acceptable diluent or carrier. |
申请公布号 |
NZ234528(A) |
申请公布日期 |
1997.06.24 |
申请号 |
NZ19900234528 |
申请日期 |
1990.07.16 |
申请人 |
SCOTIA HOLDINGS PLC (FORMERLY EFAMOL HOLDINGS PLC) |
发明人 |
HORROBIN, DAVID FREDERICK |
分类号 |
A23L33/20;A61K31/20;A61K31/23;A61P3/04;A61P3/08 |
主分类号 |
A23L33/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|